Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-729.81	-227.58	-27.43
Graham Fair Price	-62.64	3.20	8.57
PEG	2454.62	0.41	-0.02
Price/Book	-30.75	1.01	1.45
Price/Cash Flow	84.17	-21.79	-137.65
Prices/Earnings	-419.00	-35.48	-6.84
Price/Sales	-18.13	9.23	11.27
Price/FCF	84.17	-21.79	-137.65
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	47.48	0.42	0.29
Operating Margin	88.73	-0.05	-0.48
ROA	86.15	< 0.005	-0.03
ROE	-0.05	< 0.005	86.66
ROIC	-0.04	< 0.005	89.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	0.17	-14.74
Dividends QOQ	-0.94	3.69	292.21
EBIT QOQ	-8.27	0.90	-89.08
EPS QOQ	-4.26	0.86	-79.68
FCF QOQ	-3.71	-3.41	8.01
Revenue QOQ	0.02	-0.15	538.25
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	236.43	354.91	50.11
Days Sales Outstanding (DSO)	216.40	268.67	24.15
Inventory Turnover	0.38	0.25	-33.38
Debt/Capitalization	0.20	0.18	-10.43
Quick Ratio	3.54	3.70	4.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.84	8.01	2.28
Cash	3.79	3.35	-11.50
Capex	-0.22	-0.09	59.77
Free Cash Flow	-0.08	-0.37	-347.32
Revenue	1.01	0.87	-13.49
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.78	5.07	6.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.93	30.93	957.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating